K. Yu

发表

Structure-activity relationship studies on chalcone derivatives. the potent inhibition of chemical mediators release.

L. Tsao, Jih P. Wang, Chun-nan Lin, 2003, Bioorganic & medicinal chemistry.

Novel carbohydrate transformations discovered en route to natural products

C. W. Andrews, A. Ratcliffe, P. Konradsson, 1989 .

Synthesis and antiviral activity of methyl derivatives of 9-[2-(phosphonomethoxy)ethyl]guanine.

J. C. Martin, A. Patick, J. Bronson, 1992, Journal of medicinal chemistry.

Solid-phase synthesis of benzisothiazolones as serine protease inhibitors.

N. Meanwell, S. Seiler, D. Roberts, 1999, Bioorganic & medicinal chemistry letters.

Synthesis and Antiviral Activity of Methyl Derivatives of 9-(2-( Phosphonomethoxy)ethyl)guanine.

A. Patick, J. Bronson, R. Datema, 1992 .

Synthesis and antiviral activity of 2'-substituted 9-[2-(phosphonomethoxy)ethyl]guanine analogues.

J. C. Martin, A. Patick, J. Bronson, 1993, Journal of medicinal chemistry.

Molecular mechanism underlying the action of a novel fusion inhibitor of influenza A virus

N. Meanwell, C. Cianci, M. Krystal, 1997, Journal of virology.

Application of the Heck reaction in the synthesis of truncated naphthoic acid retinoids

J. Starrett, P. Reczek, J. Ostrowski, 1996 .

Synthesis of 1,3-diamino-2-hydroxypropane derivatives as pseudosymmetric HIV protease inhibitors

W. Harte, Kuo-Long Yu, M. Mansuri, 1993 .

Salicylamide inhibitors of influenza virus fusion.

N. Meanwell, M. Deshpande, C. Cianci, 2000, Bioorganic & medicinal chemistry letters.

An approach to the identification of potent inhibitors of influenza virus fusion using parallel synthesis methodology.

N. Meanwell, M. Deshpande, C. Cianci, 2001, Bioorganic & medicinal chemistry letters.

Novel quinolizidine salicylamide influenza fusion inhibitors.

N. Meanwell, C. Cianci, M. Krystal, 1999, Bioorganic & medicinal chemistry letters.